We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KLAC:NASDAQKLA Corporation Analysis

Data as of 2026-07-29 - not real-time

$173.09

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

KLA Corporation posted a record fiscal year with GAAP revenue of $13.58 billion and EPS of $3.66, yet the stock slipped more than 10% after guidance was seen as cautious, leaving the share price at $173.09 – still well above the DCF‑derived fair value of roughly $45. Technical metrics show the price trading just above the 20‑day SMA (≈$219) but below the 50‑day SMA (≈$221), with a 30‑day volatility near 97% and a beta exceeding 2.5, indicating pronounced price swings. The RSI of ~33 suggests the stock is in oversold territory, while a bearish MACD histogram (‑5.45) points to short‑term momentum weakness. Despite the steep valuation premium (PE ~49 versus industry ~31, PB ~39), the company delivers exceptional profitability (gross margin >61%, operating margin >41%) and a stellar ROE near 95%, supported by solid cash generation and a modest payout ratio of 21%. Recent analyst coverage remains bullish, with a consensus “Buy” rating, median price target of $227.5 and notable upside potential of ~35% relative to current levels, even as the broader semiconductor sector experiences profit‑taking. Market sentiment is currently in an “Extreme Greed” phase (Fear‑Greed Index 86.9), which may further amplify price volatility. Investors should weigh the near‑term price weakness against the company’s durable competitive moat and long‑term secular demand for advanced wafer‑inspection equipment.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near immediate support around $171.4
  • Oversold RSI and bearish MACD signal potential short‑term bounce
  • Recent earnings miss on guidance creates near‑term uncertainty

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong revenue growth and high operating margins
  • Robust cash flow and low payout ratio support dividend sustainability
  • Analyst price targets imply ~35% upside despite current overvaluation

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Secular demand for semiconductor inspection and metrology tools
  • Durable competitive advantage with high ROE and market leadership
  • Reasonable dividend yield adds total return potential over a multi‑year horizon

Key Metrics & Analysis

Financial Health

Revenue Growth11.50%
Profit Margin35.66%
P/E Ratio49.0
ROE94.98%
ROA21.28%
Debt/Equity105.40
P/B Ratio38.8
Op. Cash Flow$4.4B
Free Cash Flow$2.9B
Industry P/E31.5

Technical Analysis

TrendNeutral
RSI32.9
Support$171.44
Resistance$290.84
MA 20$218.96
MA 50$221.03
MA 200$161.74
MACDBearish
VolumeDecreasing
Fear & Greed Index86.93

Valuation

Fair Value$45.21
Target Price$234.04
Upside/Downside35.21%
GradeOvervalued
TypeGrowth
Dividend Yield0.48%

Risk Assessment

Beta2.74
Volatility96.83%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.